Eli Lilly to Spend $260M on Indianapolis Expansion
Apr 03, 2013
Bloomberg Businessweek
Drugmaker Eli Lilly and Co. is planning to spend about $260 million to expand insulin production and make other capital improvements to sites in its home city of Indianapolis.The company plans to spend about $180 million on new construction, the addition of another insulin cartridge-filling line, and the installation of new equipment. Read the full story
Show Comments
Join the discussion
We welcome your thoughtful comments.
All comments will display your user name.
Comments
No one has commented on this page yet.
RSS feed for comments on this page | RSS feed for all comments